ipl-logo

Eli Lilly Essay

977 Words4 Pages

Introduction
The pharmaceutical industry is ever changing and always growing, no matter what country you may live in pharmaceuticals are necessary. This industry is associated with major modifications and innovations which require extensive research to be conducted on an ongoing basis. In order to remain competitive and viable pharmaceutical companies have allocated resources to research and development.
Eli Lilly is a pharmaceutical company that was founded by Colonel Eli Lilly, who was a pharmacist who had served in the Union Army during the Civil war. In 1876 Eli Lilly purchased a small laboratory on Pearl Street in Indianapolis, Indiana. The Eli Lilly Company has seen a lot of success over the years through their production of various …show more content…

*Asset 2: OFC (olanzapine-fluoxetine combination)- OFC combined the active ingredient in Zypreza and the active ingredient in Prozac.
*Asset 3: 5HT2 antagonist SSRI- different specificities in the receptor sites for serotonin, resulting in diverse side effect profiles and efficacy for targeted symptoms.
* Asset 4: Business development Opportunities- through market surveillance and due diligence, Lilly identified 13 opportunities to in-license compounds for the treatment of depression from other pharmaceutical companies at various stages in their development.
*Asset 5: Cymbalta (duloxetine)- Cymbalta was a serotonin and norepinephrine receptor inhibitor (SNRI) that was developed by Lilly in the early 1990s for the MMD(Major Depressive Disorder) market.
* (Ofek & Laufer, 2008, p. …show more content…

With this discovery The Eli Lilly Company can now use Cymbalta to treat chronic pain and depression in patients. However, the main strategic issues and problems that Eli Lilly and Company faced with this discovery is that: option 1 “conduct a new set of clinical trials to establish a one-a-day dosage of 60mg for Cymbalta to treat major depressive disorder… option two invest in the clinical trials for a new indication that could potentially establish a point of differentiation between Cymbalta and existing antidepressants … option three is to delay the submission of Cymbalta to the FDA for marketing approval” (Ofek & Laufer, 2008, p. 2). In developing a new drug like Cymbalta the NAT would have to focus in on their clinical trials and allow for proper research and development to minimize on the severity of side effects. However in order complete clinical trials on a large scale budget $25-$50 million dollars has to be allocated towards this process. “This includes design, enroll patients, analyze and document the findings of the clinical trial” (Ofek & Laufer, 2008, p.

Show More
Related
637 Words | 3 Pages

The video “Ride the Tiger: A guide through the Bipolar Brain” introduced and explored new insights in brain science that are being used to create new and more effective treatments for Bipolar and depression. It is important to understand about how the biological components of these disorders affect our patents and how effective medication can be. I can use this information to guide clinical decisions when working with clients who suffer from Bipolar or Depression. Initially, this video gave me a greater understanding about how much biology affects these disorders and the importance of incorporating referrals to a psychiatrist is in our work. Using medication to address these disorders can be a life and death issue because of the prevalence of suicide risk associated with them.

Read More
1731 Words | 7 Pages

Watter’s observation of GlaxoSmithKline’s sneaky ways of advertising their product shows that companies want to give their consumers the illusion that they have control. They also want their customers to have confidence in their choice. They are making it okay to have depression, which is a complete transformation

Read More
1451 Words | 6 Pages

128-129). To treat depressive disorders, therapist needs to address the individual suffering from this disorder by talking to them and finding a way to help them understand their frustration and not allowing it to interfere and control their daily life. And in some cases, medication is prescribed such as, selective serotonin reuptake inhibitors, tricyclics antidepressants, monoamine oxidase inhibitors within four to six weeks, and is revolved within twelve weeks. However, medication is continued for six to twelve months so that an individual does not

Read More
696 Words | 3 Pages

Pharmacists would create their own medicines, which wasn't monitored. In the Gilded Age things began to change and there was much more room for growth, especially within the pharmaceutical industry. The pharmaceutical industry was one of the top industries in the United States. The pharmaceutical association, which was founded in 1867, would create the fundamental laws for the standards necessary for pharmacies. The pharmaceutical industry kept on expanding and growing and eventually would help lower the price of drugs and would become a key part to the American economy.

Read More
1581 Words | 7 Pages

Madison in this book has explored the life of Eli Lilly, as a businessman, a philanthropist and a citizen of Indianapolis. He has tried to envision Lilly’s life as an extension over a wide range of endeavors in which he made major contributions. Under his active leadership, the pharmaceutical company he joined in 1907 evolved into one of America’s most successful business. Although hardworking, Lilly acquired diverse interests outside the pharmaceutical company.

Read More
1444 Words | 6 Pages

It is common, for example, in people with parkinson’s disease that anticholinergic agents are used to control bladder over activity, and benzodiazepines for anxiety. Only when Parkinson’s disease medications have been reduced as much as can be tolerated, then quetiapine is to be considered. This recommendation is not evidence based and is instead based on the experience of clinicians. Clozapine, despite level 1 evidence to support its use, was also to be “considered” due to the logistical problem of blood monitoring. The committee felt that quetiapine, although not having randomized controlled trial data to support its use, did have the data to support its safety, whereas all other atypical antipsychotics, excepting clozapine, did not.

Read More
1205 Words | 5 Pages

Doctors over prescribe antidepressants to children and adolescents. This passage from the article "Still in a crib yet given antipsychotics" states that "Almost 20,000 prescriptions for risperidone (commonly known as Risperdal), quetiapine (Seroquel) and other antipsychotic medications were written in 2014 for children 2 and younger, a 50 percent jump from 13,000 just one year before, according to the prescription data company IMS Health. Prescriptions for the antidepressant fluoxetine (Prozac) rose 23 percent in one year for that age group, to about 83,000" (p.2). This evidence shows how much prescriptions for

Read More
2813 Words | 12 Pages

The point is that not everyone truly needs antidepressants. There are people in this world who suffer from real, clinical depression. These are people like me. Here are my confessions: I put on a happy face. The world doesn't need to know every single one of my mental neuroses.

Read More
1336 Words | 6 Pages

These medications are all anti-depressants that have been proven to be successful for many

Read More
779 Words | 4 Pages

Serotonin is thought of “as a chemical that is responsible for maintaining mood balance.” Doctors may prescribe an SSRI to the individual with depression. SSRI stands for selective serotonin reuptake inhibitor. There are many SSRIs to choose from, Zoloft and Prozac are the two of the more commonly known medications. These are meant to increase the amount of serotonin in a person's system.

Read More
930 Words | 4 Pages

At first there was only one type of antidepressant but now since there are more medication doctors are prescribing antidepressants more often. “The second most common prescription

Read More
586 Words | 3 Pages

Robert J. Valuk and his colleges looked at over 20,000 people with first time diagnoses of depression. "At least 6 months of follow-up data were available, which showed that treatment with SSRIs, other antidepressants, or combinations of antidepressants did not increase the risk of suicide attempts.” However, an impressive article was written by Dr. Richard A. Friedman, a professor of clinical psychiatry at Weill Cornell Medical College, and Dr. Andrew C. Leon who is also a professor at Weill Cornell of biostatistics in psychiatry, and member of the FDA's Psychopharmacologial Drugs Advisory Committee. In their article, the two argue that "Clinicians have known for years that during the first few weeks of treatment with antidepressants, some patients become “activated” —energized and agitated — before their depressed mood lifts, and that combination makes them more likely to act on preexisting suicidal

Read More
668 Words | 3 Pages

The FDA warnings regarding antidepressants go over increased sensitivity to feelings of suicidality in all ages and that all patients taking antidepressants should be observed closely throughout the first few months of trial for any change in behavior, suicidality, or clinical worsening. The warning produced by the FDA does hit the main points when discussing the basics of beginning a new prescription. The FDA does not produce a warning that is thorough and strict. The warning should be revised to speak about the spectrum of depression beginning with mild to severe, and the side effects that belong to each level of depression. Along with going over additional side effects, the warning should consist of a more strict evaluation plan such

Read More
666 Words | 3 Pages

• Antidepressants – Remeron (Mirtazapine), Cymbalta (Duloxetine), Nardil (Phenelzine), Prozac (Fluoxetine), Paxil (Paroxetine) and Anafranil (Clomipramine). • Anti-Anxiety – Valium (Diazepam), Xanax (Alprazolam), Atarax (Hydroxyzine), BuSpar (Buspirone), Librium (Chlordiazepoxide). • Depressants – Atropen (Atropine), Flexeril (Cyclobenzaprine), Soma

Read More
720 Words | 3 Pages

PORTERS FIVE FORCES ANALYSIS - PHARMA INDUSTRY Using Porter's Five Forces we can analyse the scope of the pharmaceutical industry. It looks into five factors namely, competitive rivalry, threat of new entrants, threat of substitute products, bargaining power of suppliers and bargaining power of customers. " Competitive rivalry: The pharmaceutical industry is highly fragmented with almost 3,000 pharma companies and 10,500 manufacturing units. Due to increasing demand of high-quality drugs, low-to-moderate entry barrier to the new entrant, the presence of a number of large and small firm this market is highly competitive.

Read More

More about Eli Lilly Essay

Related Topics

Open Document